Pulmonary metastasectomy can be used to manage retroperitoneal sarcoma metastases

Select patients with lung metastases from retroperitoneal sarcomas can effectively be managed with pulmonary metastasectomy, according to a study.

This single-center, retrospective cohort study included 24 patients who underwent pulmonary metastasectomy for lung metastases from retroperitoneal sarcoma. Most patients (n = 19) had retroperitoneal sarcoma.

The median overall survival was 49.9 months. The 3-year survival rate after the first pulmonary metastasectomy was 62.5% and the 5-year survival rate was 26.4%.

Age ≥56 years, disease-free interval <15 months, and size of metastasis (≥ 27 mm) were associated with poor survival.

Reference
Takatsu F, Yamamoto H, Tomioka Y, et al. Survival and prognostic factors in patients undergoing pulmonary metastasectomy for lung metastases from retroperitoneal sarcoma. World J Surg Oncol. 2022;20(1):114. doi: 10.1186/s12957-022-02552-y. PMID: 35395855.